IDEAYA Biosciences, Inc. Gains 30.7%

IDEAYA Biosciences, Inc. (IDYA:NASDAQ) jumped higher at $12.09, representing a gain of 30.7%. On Mon, Sep 12, 2022, IDYA:NASDAQ touched a New 2-Week High of $12.09. The stock got featured on our News Catalysts scanner on Mon, Sep 12, 2022 at 05:39 PM in the 'BIOTECH' category. From Mon, Aug 29, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days

About IDEAYA Biosciences, Inc. (IDYA:NASDAQ)

IDEAYA Biosciences Inc an oncology-focused medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.